about
Value-based medicine and ophthalmology: an appraisal of cost-utility analyses.The goal of value-based medicine analyses: comparability. The case for neovascular macular degeneration.Impact of Diabetic Retinopathy on Health-related Quality of Life in Iranian Diabetics.What explains health in persons with visual impairment?The reproducibility of ophthalmic utility valuesGlaucoma patients' assessment of their visual function and quality of lifeIntraocular lenses for the treatment of age-related cataracts: an evidence-based analysis.Evaluation of the relationship between quality of vision and visual function in Japanese glaucoma patients.Health state utilities in patients with diabetic retinopathy, diabetic macular oedema and age-related macular degeneration: a systematic review.Visual impairment as a function of visual acuity in both eyes and its impact on patient reported preferences.Simulation contact lenses for AMD health state utility values in NICE appraisals: a different reality.Value-based medicine: concepts and applicationQuality of life and systemic comorbidities in patients with ophthalmic disease.Utility values and myopia in teenage school studentsCost effectiveness of treatment for amblyopia: an analysis based on a probabilistic Markov modelDegree, duration, and causes of visual loss in uveitis.Quality of life in age-related macular degeneration: a review of the literature.The Clinical Effectiveness and Cost-Effectiveness of Screening for Age-Related Macular Degeneration in Japan: A Markov Modeling Study.Validity of EuroQOL-5D, time trade-off, and standard gamble for age-related macular degeneration in the Singapore populationFormal and informal care utilisation amongst elderly persons with visual impairment.Cost effectiveness of collagen crosslinking for progressive keratoconus in the UK NHS.SF-6D utility values for the better- and worse-seeing eye for health states based on the Snellen equivalent in patients with age-related macular degeneration.Comparative cost-effectiveness analysis of descemet stripping automated endothelial keratoplasty versus penetrating keratoplasty in the United States.Cost-Utility Analyses of Cataract Surgery in Advanced Age-Related Macular Degeneration.Predictors of visual outcome following surgical resection of medial sphenoid wing meningiomasSingle-site Baseline and Short-term Outcomes of Clinical Characteristics and Life Quality Evaluation of Chinese Wet Age-related Macular Degeneration Patients in Routine Clinical Practice.Retinal Prosthesis System for Advanced Retinitis Pigmentosa: A Health Technology Assessment.An updated estimate of costs of endophthalmitis following cataract surgery among Medicare patients: 2010-2014.Advances in bone marrow stem cell therapy for retinal dysfunction.Seizure Outcomes in Occipital Lobe and Posterior Quadrant Epilepsy Surgery: A Systematic Review and Meta-Analysis.Cost-effectiveness of screening for open angle glaucoma in developed countries.Visual processing in patients with age-related macular degeneration performing a face detection test.Response to: Comment on 'Cost effectiveness of collagen crosslinking for progressive keratoconus in the UK NHS'.How much blue light should an IOL transmit?A Value-Based Medicine cost-utility analysis of genetic testing for neovascular macular degeneration.The comparative effectiveness and cost-effectiveness of ranibizumab for neovascular macular degeneration revisited.Triple combination therapy and zeaxanthin for the treatment of neovascular age-related macular degeneration: an interventional comparative study and cost-effectiveness analysis.The cost-effectiveness of bevacizumab, ranibizumab and aflibercept for the treatment of age-related macular degeneration-A cost-effectiveness analysis from a societal perspective.
P2860
Q31151282-77FD1194-99C6-4117-8571-2967C143C747Q33329793-3AB2440F-044A-49CF-AA32-0CDB0CD06BE3Q33593570-4032117F-6951-415D-AB0E-5CF04D2BD0C1Q33609137-438BF643-B18A-4595-92EB-23135F3090C3Q34331192-FE3A14A9-E0FA-4B8A-B246-78FB2B3EA561Q34331239-5F3AC662-DD2F-4BDB-AF0A-B0F0C56AA247Q34449248-3F7F7CAD-BD5F-4896-98B2-1FF2005ADD36Q34729078-225DA5D3-07DC-441C-9335-9CB45E025DE4Q35059037-4BCF2696-A917-45C0-8FA8-5BE2A3AA2D19Q35067381-F592DF12-A6EC-4593-99DD-1C32950AB50BQ35350981-11A8DFA1-36FF-4495-B3D0-B0C86B9643C6Q35438629-8711D6ED-B60B-484D-88F8-B6ADC2BEBE35Q35589372-9170FE87-76FE-4C82-A9FB-E462A563324AQ35590636-65C9D944-0C28-4BF3-AB41-A1C678BE547AQ35592050-401AE91E-0300-440A-8A4E-C266D9470D56Q35592376-A80941AE-91AA-4A9F-BA99-3420682D1700Q35606970-E06BB3A7-FDF9-4576-89CD-0628E29F6041Q35716443-F0CF80AF-B8BB-41E8-916A-719A4CC78C16Q35820332-1751B1B6-D28E-4278-AD8D-265201F48CD3Q36025831-EB9621FC-AAD1-4DD7-A03A-026B0A26F783Q36281455-14593D01-2F86-48C5-9B38-360E0442E4E2Q36287461-49893D00-D617-421C-A732-33CCEDCEC552Q36468029-C5E613D7-DC24-4C45-A6E5-F43E165B6E81Q36504075-61B881AD-FF39-46F0-8A2D-06B216BE6D98Q36627583-F1B5D6E1-67BC-4FF1-A333-219D2F917DEFQ36797862-C1569465-DB6E-4B14-BD5A-F3BE426A5E44Q37101490-7C0383FE-1A0A-451D-9EE6-D338A3822755Q37381508-40F21904-AB84-4BF1-B0C1-E95F5FEDA599Q38804673-00CA25E8-263E-4936-A3D0-A35EB442B163Q39248455-0619C23C-C19F-41F4-9EC0-C158B6679BC4Q39803728-90C6DA28-4578-454D-8F72-3DBA1C5FAD8CQ40983763-7C11D399-129C-4696-A3B3-F97260AEB313Q42355391-CD8B6ECA-4890-4A55-B9F5-B5EDDF8CE472Q42535902-6FDFCCF8-4E2A-4CE1-A1BA-DAB58C582EF5Q51324823-3B89122A-3AC6-4F9F-9B32-C531CA667529Q53438701-BF99952F-DF8E-41BB-A77F-17018DE5554EQ54571267-B70819D5-FAE7-4E53-8678-8C28F36BBCDAQ54969941-4906CDDC-24E8-4C9C-BE01-AF4BA27B49A7
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Vision and quality-of-life
@ast
Vision and quality-of-life
@en
Vision and quality-of-life
@nl
type
label
Vision and quality-of-life
@ast
Vision and quality-of-life
@en
Vision and quality-of-life
@nl
prefLabel
Vision and quality-of-life
@ast
Vision and quality-of-life
@en
Vision and quality-of-life
@nl
P2860
P1476
Vision and quality-of-life
@en
P2093
P2860
P304
P577
1999-01-01T00:00:00Z